Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.2989 | 91 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.7286 | 92 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.60249 | 92 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.64384 | 91 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.40154 | 91 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.21732 | 91 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.6307 | 88 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.35754 | 91 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.21176 | 90 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.64602 | 92 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.65203 | 92 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.41498 | 91 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.17371 | 90 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.53895 | 92 |